登入
選單
返回
Google圖書搜尋
Identification of a Genetic Variation in ERAP1 Aminopeptidase that Prevents Human Cytomegalovirus MiR-UL112-5p-mediated Immunoevasion
Paolo Romania
Loredana Cifaldi
Benedetta Pignoloni
Nadia Starc
Valerio D'Alicandro
Ombretta Melaiu
Giuseppina Li Pira
Ezio Giorda
Rosalba Carrozzo
Monika Bergvall
Tomas Bergström
Lars Alfredsson
Tomas Olsson
Ingrid Kockum
Ilkka Seppälä
Terho Lehtimäki
Mikko A. Hurme
Hartmut Hengel
Angela Santoni
Cristina Cerboni
Franco Locatelli
Mauro D'Amato
Doriana Fruci
出版
Universität
, 2017
URL
http://books.google.com.hk/books?id=OGqVzgEACAAJ&hl=&source=gbs_api
註釋
Abstract: Herein, we demonstrate that HCMV miR-UL112-5p targets ERAP1, thereby inhibiting the processing and presentation of the HCMV pp65495-503 peptide to specific CTLs. In addition, we show that the rs17481334 G variant, naturally occurring in the ERAP1 3′ UTR, preserves ERAP1 from miR-UL112-5p-mediated degradation. Specifically, HCMV miR-UL112-5p binds the 3′ UTR of ERAP1 A variant, but not the 3′ UTR of ERAP1 G variant, and, accordingly, ERAP1 expression is reduced both at RNA and protein levels only in human fibroblasts homozygous for the A variant. Consistently, HCMV-infected GG fibroblasts were more efficient in trimming viral antigens and being lysed by HCMV-peptide-specific CTLs. Notably, a significantly decreased HCMV seropositivity was detected among GG individuals suffering from multiple sclerosis, a disease model in which HCMV is negatively associated with adult-onset disorder. Overall, our results identify a resistance mechanism to HCMV miR-UL112-5p-based immune evasion strategy with potential implications for individual susceptibility to infection and other diseases